by Jovana Drinjakovic | Jun 15, 2018
Plagued by failures of early human studies from the 1990s, including the death of a patient, gene therapy is making a comeback with promising results. And it has a tiny virus to thank. After the first 2012 European gene therapy approval for a liver disease, and last...
by Stacey Johnson | Jun 1, 2018
Are you familiar with The Conversation – not to be confused with The Conversation with Amanda De Cadenet? Amanda De Cadenet is one busy lady who makes television and online shows for, and about, women. The Conversation is a not-for-profit media outlet that publishes...
by Samantha Payne | May 24, 2018
The ability to revert a terminally differentiated, somatic cell back to a pluripotent stem cell state has been of incalculable value to researchers since its discovery in 2006. In recent years, researchers have modified this technique by cutting out a step, allowing...
by Jovana Drinjakovic | Apr 25, 2018
Miniature human brains continue to develop when hooked up to a blood supply in the mouse brain in a finding that opens up new avenues for learning how the brain forms and falls ill, while at the same time raising ethical questions. Last week, two teams reported...
by Stacey Johnson | Mar 30, 2018
Canada’s reputation for excellent science in the field of regenerative medicine can be traced back to the University of Toronto (U of T). Quite literally, Drs. James Till and Ernest McCulloch were U of T researchers when they discovered stem cells in the early 1960s....
by Stacey Johnson | Feb 23, 2018
If you follow amyotrophic lateral sclerosis (ALS) research, you may be interested to know that ALS Canada is holding a free webinar (registration link enclosed) on February 28 to explain how funds from the ALS #Icebucketchallenge from 2014 were spent. Do you remember...
Comments